---
title: "Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Investors to Learn More About the Investigation"
description: "Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased PACS Group, Inc. securities before April 11, 2024. The investigation focuses on possible corpo"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/252384491.md"
published_at: "2025-08-10T15:00:03.000Z"
---

# Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PACS Group, Inc. (PACS) and Encourages Investors to Learn More About the Investigation

> Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of investors who purchased PACS Group, Inc. securities before April 11, 2024. The investigation focuses on possible corporate wrongdoing by PACS Group and its officers or directors. Investors are encouraged to visit the firm's website for more information and to assist in the investigation. The firm operates on a contingency fee basis, meaning they only charge if successful in recovering funds for investors.

NEW YORK CITY, NY / ACCESS Newswire / August 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") . Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PACS.

**Investigation Details**

The investigation concerns whether PACS Group and certain of its officers and/or directors have engaged in corporate wrongdoing.

**What's Next?**

If you are aware of any facts relating to this investigation or purchased PACS Group shares, you can assist this investigation by visiting the firm's site: bgandg.com/PACS. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC:

**There is No Cost to You**

We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

**Why Bronstein, Gewirtz & Grossman**

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.

Follow us for updates on LinkedIn, X, Facebook, or Instagram.

Attorney advertising. Prior results do not guarantee similar outcomes.

**Contact**

**SOURCE:** Bronstein, Gewirtz & Grossman, LLC

View the original press release on ACCESS Newswire

### Related Stocks

- [PACS.US - PACS](https://longbridge.com/en/quote/PACS.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| PACS 集团公司将出席摩根大通医疗保健会议并进行演讲 | PACS Group, Inc. 将于 2026 年 1 月 13 日下午 5:15（太平洋时间）在摩根大通医疗会议上进行演讲。演讲将由董事长兼首席执行官 Jason Murray 和执行副总裁兼临时首席财务官 Mark Hancock 主 | [Link](https://longbridge.com/en/news/272319115.md) |
| 在最近的交易之后，PACS 集团（PACS）加强了合规和人力资源领导力，投资者可能会如何回应 | PACS Group, Inc. 任命 Kelly Priegnitz 为首席合规官，Trent Bingham 为首席人力资源官，此举旨在增强其在合规和人力资源管理方面的领导力，以应对近期的收购。这些任命旨在加强公司在扩展专业护理业务时的 | [Link](https://longbridge.com/en/news/270389390.md) |
| 每千次展示 60 美元！OpenAI 用高价拉开 “AI 广告” 大幕 | 为应对 AI 巨额开支，OpenAI 正式测试广告，CPM60 美元起步、最低投入 20 万美元，定位高端渠道，直接挑战谷歌万亿美元市场，WPP 等顶级代理已率先合作。但转型风险并存：需平衡用户信任，承诺不用私聊数据；对手 Anthropi | [Link](https://longbridge.com/en/news/275993077.md) |
| 领先汽车配件的沉重债务负担加剧了流动性、再融资以及业务扭转的风险 | Advance Auto Parts Inc (AAP) 正面临重大财务风险，主要由于其沉重的债务负担，这可能限制流动性和融资渠道。这种情况可能迫使更多现金流用于偿债，而非投资，从而增加对经济衰退和潜在契约违约的脆弱性。在严峻的信贷环境中， | [Link](https://longbridge.com/en/news/275997122.md) |
| 伊本·阿尔·海赛姆医院全年收入为 301,281 第纳尔 | 伊本·海瑟姆医院公司 PSC (IBNH.AM)：伊本·海瑟姆医院财年税后净收入为 301,281 第纳尔；伊本·海瑟姆医院财年收入为 1210 万第纳尔 | [Link](https://longbridge.com/en/news/275996849.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.